共 50 条
- [4] Role of daclizumab as a calcineurin inhibitor-sparing agent following heart transplantation. PHARMACOTHERAPY, 2005, 25 (10): : 1490 - 1491
- [5] Steroid or calcineurin inhibitor-sparing immunosuppressive protocols KIDNEY TRANSPLANTATION : STRATEGIES TO PREVENT ORGAN REJECTION, 2005, 146 : 30 - 42